ABCB1 (P-glycoprotein, MDR1), ABCC1-C6 (MRP1-6) and ABCG2 (BCRP) confer resistance to cytostatic drugs of tumors and contribute to the failure of tumor chemotherapy [25]. Here, ABCG2 is linked to neoplasm.